Product
Matching placebo rectal foam
1 clinical trial
1 indication
Indication
ulcerative colitisClinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam BID for 2 Weeks, Followed by QD for 4 Weeks, in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative ColitisStatus: Not yet recruiting, Estimated PCD: 2025-06-01